Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Colon Cancer|Pancreatic Cancer|Head and Neck Cancer|Kidney Cancer|Sarcoma|Hepatocellular Cancer
Interventions: DRUG: Pazopanib|DRUG: Ixabepilone
Sponsor: Masonic Cancer Center, University of Minnesota
Collaborators: GlaxoSmithKline